Manning & Napier Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.72M Buy
83,027
+168
+0.2% +$13.6K 0.09% 134
2026
Q1
$7.18M Sell
82,859
-14,578
-15% -$1.4M 0.1% 125
2025
Q4
$9.42M Sell
97,437
-19,237
-16% -$1.87M 0.12% 99
2025
Q3
$11.1M Sell
116,674
-112,808
-49% -$10.4M 0.14% 85
2025
Q2
$20M Sell
229,482
-37,968
-14% -$3.22M 0.24% 74
2025
Q1
$24M Sell
267,450
-21,667
-7% -$1.94M 0.3% 69
2024
Q4
$23.1M Sell
289,117
-30,170
-9% -$2.61M 0.26% 71
2024
Q3
$28.7M Sell
319,287
-6,506
-2% -$547K 0.32% 67
2024
Q2
$25.6M Buy
+325,793
New +$26.7M 0.29% 72
2017
Q3
$411M Buy
5,289,068
+90,922
+2% +$7.55M 3.52% 1
2017
Q2
$461M Sell
5,198,146
-466,989
-8% -$39.4M 3.97% 1
2017
Q1
$456M Sell
5,665,135
-1,107,753
-16% -$86.5M 3.54% 2
2016
Q4
$482M Buy
6,772,888
+114,113
+2% +$8.97M 3.16% 2
2016
Q3
$575M Sell
6,658,775
-404,040
-6% -$35.2M 3.53% 1
2016
Q2
$613M Sell
7,062,815
-733,055
-9% -$59.3M 3.71% 1
2016
Q1
$585M Buy
7,795,870
+2,779,660
+55% +$209M 3.39% 1
2015
Q4
$386M Buy
5,016,210
+2,344,290
+88% +$176M 2.25% 16
2015
Q3
$179M Buy
+2,671,920
New +$197M 0.96% 43
2014
Q2
Sell
-203,440
Closed -$12.5M 380
2014
Q1
$12.5M Buy
203,440
+821
+0.4% +$47.8K 0.05% 150
2013
Q4
$11.6M Sell
202,619
-158,785
-44% -$9M 0.05% 138
2013
Q3
$19.2M Buy
361,404
+5,895
+2% +$317K 0.09% 106
2013
Q2
$18.3M Buy
+355,509
New +$17.6M 0.1% 106

Other funds holding MDT

Manning & Napier Advisors's MDT Position: Q2 2026 in Review

Manning & Napier Advisors increased its Medtronic (MDT) stake by 0.2% in Q2 2026, buying an estimated $13.6K and bringing the position to 83,027 shares worth $6.72M. The position accounts for 0.09% of the portfolio, ranked #134.

Manning & Napier Advisors first reported a position in MDT in Q2 2013 and has held it in 22 quarters since. The position peaked at $613M in Q2 2016. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Manning & Napier Advisors held 83,027 shares of Medtronic worth $6.72M as of Q2 2026.
  • Manning & Napier Advisors bought 168 Medtronic shares in Q2 2026, an estimated $13.6K.
  • Medtronic made up 0.09% of Manning & Napier Advisors's portfolio in Q2 2026, its #134 holding.
  • Manning & Napier Advisors first reported a position in Medtronic in Q2 2013 and has held it in 22 quarters since.
  • Manning & Napier Advisors's Medtronic position peaked at $613M in Q2 2016.
  • 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.